Literature DB >> 35167332

Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study.

Giuseppe Tarantini, Luca Nai Fovino, Andrea Scotti1, Mauro Massussi1, Francesco Cardaioli1, Giulio Rodinò1, Alice Benedetti1, Mauro Boiago1, Yuji Matsuda2, Saverio Continisio1, Carolina Montonati1, Luisa Cacciavillani1, Andrea Pavei1, Giulia Masiero1, Massimo Napodano1, Chiara Fraccaro1, Tommaso Fabris1, Sabino Iliceto1.   

Abstract

BACKGROUND: Coronary access (CA) after transcatheter aortic valve replacement (TAVR) with supra-annular transcatheter heart valves (THV) can be challenging. Specific Evolut R/Pro and Acurate Neo THVs orientations are associated with reduced neo-commissure overlap with coronary ostia, while SAPIEN 3 THV cannot be oriented. With the ALIGN-ACCESS study (TAVR With Commissural Alignment Followed by Coronary Access), we investigated the impact of commissural alignment on the feasibility of CA after TAVR.
METHODS: We performed coronary angiography after TAVR with intra-annular SAPIEN 3, supra-annular Evolut R/Pro, and Acurate Neo THVs in 206 patients. Evolut THVs were implanted aiming for commissure alignment. Alignment of Acurate Neo was retrospectively assessed in 36, intentionally attempted in 26 cases. The primary end point was the rate of unfeasible and nonselective CA after TAVR.
RESULTS: Thirty-eight percent of patients received SAPIEN 3, 31.1% Evolut Pro/R, 30.1% Acurate Neo THV. Final valve orientation was favorable to commissural alignment in 85.9% of Evolut and 69.4% of Acurate Neo cases (with intentional alignment successful in 88.5%). Selective CA was higher for SAPIEN 3 than for aligned and misaligned supra-annular THVs (95% versus 71% versus 46%, P<0.001). Cannulation of at least one coronary was unfeasible with 11% misaligned supra-annular, 3% aligned supra-annular, and 0% SAPIEN 3 THVs. Independent predictors of unfeasible/nonselective CA were implantation of a misaligned supra-annular THV (odds ratio, 4.59 [95% CI, 1.81-11.61]; P<0.01), sinus of Valsalva height (odds ratio, 0.83 [95% CI, 0.7-0.98]; P=0.03), and THV-sinus of Valsalva relation (odds ratio, 1.06 [95% CI, 1.02-1.1]; P<0.01).
CONCLUSIONS: Commissural alignment improves the rate of selective CA after TAVR with supra-annular THVs. Nevertheless, aligned supra-annular THVs carry higher risk of unfeasible/nonselective CA than SAPIEN 3. Patients with a misaligned supra-annular THV, low sinus of Valsalva, and higher THV-sinus of Valsalva relation are at highest risk of impaired CA after TAVR.

Entities:  

Keywords:  aortic valve; coronary angiography; heart valve; sinus of Valsalva; transcatheter aortic valve replacement

Mesh:

Year:  2022        PMID: 35167332     DOI: 10.1161/CIRCINTERVENTIONS.121.011045

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  5 in total

Review 1.  Commissural alignment in transcatheter aortic valve replacement: A literature review.

Authors:  Abdul Muiz Khalid; Crochan J O'Sullivan
Journal:  Front Cardiovasc Med       Date:  2022-08-09

2.  Comparison of cusp-overlap projection and standard three-cusp coplanar view during self-expanding transcatheter aortic valve replacement: A systematic review and meta-analysis.

Authors:  Yujing Chen; Gangjie Zhu; Xin Liu; Weilin Wu; Hui Chai; Minjie Tao; Dongmei Kong; Yingzi Li; Li Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-17

3.  Coronary access following ACURATE neo implantation for transcatheter aortic valve-in-valve implantation: Ex vivo analysis in patient-specific anatomies.

Authors:  Arif A Khokhar; Francesco Ponticelli; Adriana Zlahoda-Huzior; Kailash Chandra; Rossella Ruggiero; Marco Toselli; Francesco Gallo; Alberto Cereda; Alessandro Sticchi; Alessandra Laricchia; Damiano Regazzoli; Antonio Mangieri; Bernhard Reimers; Simone Biscaglia; Carlo Tumscitz; Gianluca Campo; Ghada W Mikhail; Won-Keun Kim; Antonio Colombo; Dariusz Dudek; Francesco Giannini
Journal:  Front Cardiovasc Med       Date:  2022-09-14

4.  New adverse coronary events in valve-in-valve TAVR and native TAVR-A 2-year matched cohort.

Authors:  Ofir Koren; Vivek Patel; Robert Naami; Edmund Naami; Takashi Nagasaka; Alon Shechter; Sharon Shalom Natanzon; Siamak Kohan; Zev Allison; Addee Lerner; Daniel Eugene Cheng; Tarun Chakravarty; Mamoo Nakamura; Wen Cheng; Hasan Jilaihawi; Raj R Makkar
Journal:  Front Cardiovasc Med       Date:  2022-09-21

5.  Transcatheter treatment of severe aortic stenosis in patients with complex coronary artery disease: case series and proposed therapeutic algorithm.

Authors:  Francesco Soriano; Claudio Montalto; Dario Calderone; Stefano Nava; Giuseppe Esposito; Francesco Saia; Jacopo A Oreglia; Lars Søndergaard
Journal:  Eur Heart J Case Rep       Date:  2022-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.